1. AB0827 IMPACT OF BASELINE BODY MASS INDEX ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS. (2nd June 2020) Authors: Ritchlin, C. T.; Ogdie, A.; Giles, J. T.; Gomez-Reino, J. J.; Helliwell, P.; Stockert, L.; Young, P.; Joseph, W.; Mundayat, R.; Graham, D.; Woolcott, J.; Romero, A. B. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0127 The efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index. (12th June 2018) Authors: Dikranian, A.; Gonzalez-Gay, M. A.; Wellborne, F.; Alvaro-Gracia, J. M.; Takiya, L.; Stockert, L.; Chapman, D.; Tatulych, S.; Dahl, P.; Curtis, J. R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0317 Tofacitinib in patients with psoriatic arthritis and metabolic syndrome: a post-hoc analysis of phase 3 studies. (12th June 2018) Authors: Ritchlin, C.; Giles, J.; Ogdie, A.; Gomez-Reino, J.; Stockert, L.; Young, P.; Wang, C.; Romero, A.B.; Kudlacz, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0196 TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INDICATIVE OF DEPRESSION AND/OR ANXIETY: A POST HOC ANALYSIS OF PHASE 3 AND PHASE 3B/4 CLINICAL TRIALS. (2nd June 2020) Authors: Citera, G.; Jain, R.; Irazoque-Palazuelos, F.; Guzman, R.; Madariaga, H.; Gruben, D. C.; Wang, L.; Stockert, L.; Hsu, M. A.; Santana, K.; Ebrahim, A.; Ponce de Leon, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗